{
    "PMC": "5926053",
    "DOI": "10.1111/j.1349-7006.1999.tb00735.x",
    "PMID": "10189892",
    "PMCID": "PMC5926053",
    "title": "Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol.",
    "year": 1999,
    "source_url": "https://europepmc.org/article/PMC/PMC5926053",
    "source": "MED",
    "abstract_text": "The overexpression of the oncogene product MDM2 is often observed in human breast cancer cells, especially in estrogen receptor (ER)-positive ones. To study the role of MDM2 protein in ER-positive breast cancer, we have established cell lines derived from MCF-7 which stably express increased and decreased levels of MDM2 by transfection of a mammalian expression vector containing human mdm2 cDNA in sense and antisense orientations, respectively. Interestingly, MDM2 overexpression in MCF-7 cells afforded a remarkable growth advantage under estradiol (E2)-supplemented condition. Then, we analyzed the expression of p53, which is an important regulator of growth and the cell cycle. Unexpectedly, the p53 accumulation induced by E2 was remarkably higher in MCF-7 cells stably overexpressing MDM2 than in the parent MCF-7 cells. On the other hand, reduction of MDM2 suppressed the E2-induced increase in p53 protein. Moreover, mdm2 antisense oligonucleotides prevented E2-induced accumulation of p53. In the steady state, the cellular levels of p53 were also correlated with those of MDM2. These interactions are not consistent with the well-known role of MDM2, which acts as a negative regulator for p53 by inhibiting its function and promoting its rapid degradation. These results suggest that MDM2 may regulate the expression of p53 in the steady state and in response to E2 in breast cancer cells, and imply a novel and important role of MDM2 during breast carcinogenesis.",
    "full_text": "Jpn J Cancer Res Jpn. J. Cancer Res 10.1111/(ISSN)1349-7006a CAS Japanese Journal of Cancer Research : Gann 0910-5050 1876-4673 Blackwell Publishing Ltd Oxford, UK 5926053 10189892 10.1111/j.1349-7006.1999.tb00735.x CAE210 Article Overexpression of MDM2 in MCF\u20107 Promotes Both Growth Advantage and p53 Accumulation in Response to Estradiol Saji Shigehira 1 Nakashima Shigeru 2 Hayashi Shin\u2010ichi 3 Toi Masakazu 4 Saji Shigetoyo 1 Nozawa Yoshinori 2 1 2nd Department of Surgery 2 Department of Biochemistry, Gifu University School of Medicine, 40 Tsukasa\u2010machi, Gifu 500\u20138705 3 Saitama Cancer Center Research Institute, Ina\u2010machi, Kitaadachi\u2010gun, Saitama 362\u20130806 4 Department of Surgery, Tokyo Metropolitan Komagome Hospital, 3\u201318\u201022 Honkomagome, Bunkyo\u2010ku, Tokyo 113\u20130021 * To whom correspondence should be addressed. E\u2010mail: ss-saji@wa2.so-net.ne.jp 2 1999 90 2 10.1111/cas.1999.90.issue-2 210 218 Received October 14, 1998/Revised November 30, 1998/ Accepted December 4, 1998 The overexpression of the oncogene product MDM2 is often observed in human breast cancer cells, especially in estrogen receptor (ER)\u2010positive ones. To study the role of MDM2 protein in ER\u2010positive breast cancer, we have established cell lines derived from MCF\u20107 which stably express increased and decreased levels of MDM2 by transfection of a mammalian expression vector containing human mdm2 cDNA in sense and antisense orientations, respectively. Interestingly, MDM2 overexpression in MCF\u20107 cells afforded a remarkable growth advantage under estradiol (E2)\u2010sup\u2010plemented condition. Then, we analyzed the expression of p53, which is an important regulator of growth and the cell cycle. Unexpectedly, the p53 accumulation induced by E2 was remarkably higher in MCF\u20107 cells stably overexpressing MDM2 than in the parent MCF\u20107 cells. On the other hand, reduction of MDM2 suppressed the E2\u2010induced increase in p53 protein. Moreover, mdm2 antisense oligonucleotides prevented E 2 \u2010induced accumulation of p53. In the steady state, the cellular levels of p53 were also correlated with those of MDM2. These interactions are not consistent with the well\u2010known role of MDM2, which acts as a negative regulator for p53 by inhibiting its function and promoting its rapid degradation. These results suggest that MDM2 may regulate the expression of p53 in the steady state and in response to E2 in breast cancer cells, and imply a novel and important role of MDM2 during breast carcinogenesis. Breast cancer MDM2 p53 Estrogen receptor source-schema-version-number 2.0 cover-date February 1999 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015 REFERENCES 1 ) Cahilly\u2010Snyder , L. , Yang\u2010Feng , T. , Francke , U. and George , D. L. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line . Somat. Cell Mol. Genet. , 13 , 235 \u2013 244 ( 1987 ). 3474784 2 ) Fakharzadeh , S. S. , Trusko , S. P. and George , D. L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line . EMBO J. , 10 , 1565 \u2013 1569 ( 1991 ). 2026149 3 ) Oliner , J. D. , Kinzler , K. W. , Meltzer , P. S. , George , D. L. and Vogelstein , B. Amplification of a gene encoding a p53\u2010associated protein in human sarcomas . Nature , 358 , 80 \u2013 83 ( 1992 ). 1614537 4 ) Momand , J. , Zambetti , G. P. , Olson , D. C. , George , D. and Levine , A. J. The mdm\u20102 oncogene product forms a complex with the p53 protein and inhibits p53\u2013mediated trans\u2010activation . Cell , 69 , 1237 \u2013 1245 ( 1992 ). 1535557 5 ) Kussie , P. H. , Gorina , S. , Marechal , V. , Elenbaas , B. , Moreau , J. , Levine , A. J. and Pavletich , N. P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain . Science , 274 , 948 \u2013 953 ( 1996 ). 8875929 6 ) Boddy , M. N. , Freemont , P. S. and Borden , K. L. The p53\u2013associated protein MDM2 contains a newly characterized zinc\u2010binding domain called the RING finger . Trends Biochem. Sci. , 19 , 198 \u2013 199 ( 1994 ). 8048160 7 ) Haupt , Y. , Maya , R. , Kazaz , A. and Oren , M. Mdm2 promotes the rapid degradation of p53 . Nature , 387 , 296 \u2013 299 ( 1997 ). 9153395 8 ) Kubbutat , M. H. , Jones , S. N. and Vousden , K. H. Regulation of p53 stability by Mdm2 . Nature , 387 , 299 \u2013 303 ( 1997 ). 9153396 9 ) Barak , Y. , Juven , T. , Haffner , R. and Oren , M. mdm2 expression is induced by wild type p53 activity . EMBO J. , 12 , 461 \u2013 468 ( 1993 ). 8440237 10 ) Xiao , Z. X. , Chen , J. , Levine , A. J. , Modjtahedi , N. , Xing , J. , Sellers , W. R. and Livingston , D. M. Interaction between the retinoblastoma protein and the oncoprotein MDM2 . Nature , 375 , 694 \u2013 698 ( 1995 ). 7791904 11 ) Martin , K. , Trouche , D. , Hagemeier , C. , Sorensen , T. S. , LaThangue , N. B. and Kouzarides , T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein . Nature , 375 , 691 \u2013 694 ( 1995 ). 7791903 12 ) Marechal , V. , Elenbaas , B. , Piette , J. , Nicolas , J. C. and Levine , A. J. The ribosomal L5 protein is associated with mdm\u20102 and mdm\u20102\u2010p53 complexes . Mol. Cell. Biol. , 14 , 7414 \u2013 7420 ( 1994 ). 7935455 13 ) Elenbaas , B. , Dobbelstein , M. , Roth , J. , Shenk , T. and Levine , A. J. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain . Mol. Med. , 2 , 439 \u2013 451 ( 1996 ). 8827714 14 ) Fiddler , T. A. , Smith , L. , Tapscott , S. J. and Thayer , M. J. Amplification of MDM2 inhibits MyoD\u2010mediated myogenesis . Mol. Cell. Biol. , 16 , 5048 \u2013 5057 ( 1996 ). 8756663 15 ) Pomerantz , J. , Schreiber\u2010Agus , N. , Liegeois , N. J. , Silver\u2010man , A. , Alland , L. , Chin , L. , Potes , J. , Chen , K. , Orlow , I. , Lee , H. W. , Cordon\u2010Cardo , C. and DePinho , R. A. The Ink4a tumor suppressor gene product, p1 9Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 . Cell , 92 , 713 \u2013 723 ( 1998 ). 9529248 16 ) Zhang , Y. , Xiong , Y. and Yarbrough , W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF\u2010INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways . Cell , 92 , 725 \u2013 734 ( 1998 ). 9529249 17 ) Sigalas , I. , Calvert , A. H. , Anderson , J. J. , Neal , D. E. and Lunec , J. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer . Nat. Med. , 2 , 912 \u2013 917 ( 1996 ). 8705862 18 ) Matsumoto , R. , Tada , M. , Nozaki , M. , Zhang , C. L. , Sawamura , Y. and Abe , H. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms . Cancer Res. , 58 , 609 \u2013 613 ( 1998 ). 9485008 19 ) Cordon\u2010Cardo , C. , Latres , E. , Drobnjak , M. , Oliva , M. R. , Pollack , D. , Woodruff , J. M. , Marechal , V. , Chen , J. , Bren\u2010nan , M. F. and Levine , A. J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas . Cancer Res. , 54 , 794 \u2013 799 ( 1994 ). 8306343 20 ) McCann , A. H. , Kirley , A. , Carney , D. N. , Corbally , N. , Magee , H. M. , Keating , G. and Dervan , P. A. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status . Br. J. Cancer , 71 , 981 \u2013 985 ( 1995 ). 7734324 21 ) Quesnel , B. , Preudhomme , C. , Fournier , J. , Fenaux , P. and Peyrat , J. P. MDM2 gene amplification in human breast cancer . Eur. J. Cancer , 30A, 982 , 984 ( 1994 ). 7946597 22 ) Inada , K. , Toi , M. , Yamamoto , Y. , Suzuki , A. , Kurisaki , T. , Suzuki , H. and Tominaga , T. Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer . Oncol. Rep. , 3 , 667 \u2013 671 ( 1996 ). 21594432 23 ) Hideshima , T. , Shinohara , T. , Baba , M. and Shirakusa , T. The expression of MDM2 and p53 protein in breast carcinoma . Oncol. Rep. , 4 , 297 \u2013 300 ( 1997 ). 21590046 24 ) Baunoch , D. A. , Watkins , L. F. , Tewari , A. , Reece , M. T. , Adams , L. , Stack , R. , Brown , A. , Jones , L. , Christian , D. , Latif , N. A. , Lawrence , W. D. and Lane , M. A. MDM2 overexpression in benign and malignant lesions of the human breast: association with ER expression . Int. J. Oncol. , 8 , 895 \u2013 899 ( 1996 ). 21544443 25 ) Marchetti , A. , Buttitta , F. , Girlando , S. , Dalla Palma , P. , Pellegrini , S. , Fina , P. , Doglioni , C. , Bevilacqua , G. and Barbareschi , M. mdm2 gene alterations and mdm2 protein expression in breast carcinomas . J. Pathol. , 175 , 31 \u2013 38 ( 1995 ). 7891224 26 ) Gudas , J. M. , Nguyen , H. , Kiein , R. C. , Katayose , D. , Seth , P. and Cowan , K. H. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells . Clin. Cancer Res. , 1 , 71 \u2013 80 ( 1995 ). 9815889 27 ) Roemer , K. and Friedmann , T. Modulation of cell proliferation and gene expression by a p53\u2013estrogen receptor hybrid protein . Proc. Natl. Acad. Sci. USA , 90 , 9252 \u2013 9256 ( 1993 ). 8415687 28 ) Suzuki , A. , Toi , M. , Yamamoto , Y. , Saji , S. , Muta , M. and Tominaga , T. Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma . Jpn. J. Cancer Res. , 89 , 221 \u2013 227 ( 1998 ). 9548451 29 ) Chen , L. , Agrawal , S. , Zhou , W. , Zhang , R. and Chen , J. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage . Proc. Natl. Acad. Sci. USA , 95 , 195 \u2013 200 ( 1998 ). 9419352 30 ) El\u2010Deiry , W. S. , Tokino , T. , Velculescu , V. E. , Levy , D. B. , Parsons , R. , Trent , J. M. , Lin , D. , Mercer , W. E. , Kinzler , K. W. and Vogelstein , B. WAF1, a potential mediator of p53 tumor suppression . Cell , 75 , 817 \u2013 825 ( 1993 ). 8242752 31 ) Harper , J. W. , Adami , G. R. , Wei , N. , Keyomarsi , K. and Elledge , S. J. The p21 Cdk\u2010interacting protein Cip1 is a potent inhibitor of G1 cyclin\u2010dependent kinases . Cell , 75 , 805 \u2013 816 ( 1993 ). 8242751 32 ) Dulic , V. , Kaufmann , W. K. , Wilson , S. J. , Tlsty , T. D. , Lees , E. , Harper , J. W. , Elledge , S. J. and Reed , S. I. p53\u2013dependent inhibition of cyclin\u2010dependent kinase activities in human fibroblasts during radiation\u2010induced G1 arrest . Cell , 76 , 1013 \u2013 1023 ( 1994 ). 8137420 33 ) Hurd , C. , Khattree , N. , Alban , P. , Nag , K. , Jhanwar , S. C. , Dinda , S. and Moudgil , V. K. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line . J. Biol. Chem. , 270 , 28507 \u2013 28510 ( 1995 ). 7499360 34 ) Hurd , C. , Khattree , N. , Dinda , S. , Alban , P. and Moudgil , V. K. Regulation of tumor suppressor proteins, p53 and retinoblastoma by estrogen and antiestrogens in breast cancer cells . Oncogene , 15 , 991 \u2013 995 ( 1997 ). 9285694 35 ) Yu , C. L. , Driggers , P. , Barrera\u2010Hernandez , G. , Nunez , S. B. , Segars , J. H. and Cheng , S. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways . Biochem. Biophys. Res. Commun. , 239 , 617 \u2013 620 ( 1997 ). 9344880 36 ) Hall , P. A. , McKee , P. H. , Menage , H. D. , Dover , R. and Lane , D. P. High levels of p53 protein in UV\u2010irradiated normal human skin . Oncogene , 8 , 203 \u2013 207 ( 1993 ). 8093810 37 ) Zhan , Q. , Carrier , F. and Fornace , A. J. , Jr. Induction of cellular p53 activity by DNA\u2010damaging agents and growth arrest . Mol. Cell. Biol. , 13 , 4242 \u2013 4250 ( 1993 ). 8321226 38 ) Perry , M. E. , Piette , J. , Zawadzki , J. A. , Harvey , D. and Levine , A. J. The mdm\u20102 gene is induced in response to UV light in a p53\u2013dependent manner . Proc. Natl. Acad. Sci. USA , 90 , 11623 \u2013 11627 ( 1993 ). 8265599 39 ) Lianes , P. , Orlow , I. , Zhang , Z. F. , Oliva , M. R. , Sarkis , A. S. , Reuter , V. E. and Cordon\u2010Cardo , C. Altered patterns of MDM2 and TP53 expression in human bladder cancer . J. Natl. Cancer Inst. , 86 , 1325 \u2013 1330 ( 1994 ). 8064890 40 ) Riou , G. , Barrois , M. , Prost , S. , Terrier , M. J. , Theodore , C. and Levine , A. J. The p53 and mdm\u20102 genes in human testicular germ\u2010cell tumors . Mol. Carcinog. , 12 , 124 \u2013 131 ( 1995 ). 7893365 41 ) Maestro , R. , Gloghini , A. , Doglioni , C. , Gasparotto , D. , Vukosavljevic , T. , De Re , V. , Laurino , L. , Carbone , A. and Boiocchi , M. MDM2 overexpression does not account for stabilization of wild\u2010type p53 protein in non\u2010Hodgkin's lymphomas . Blood , 85 , 3239 \u2013 3246 ( 1995 ). 7756655 42 ) Landers , J. E. , Cassel , S. L. and George , D. L. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild\u2010type p53 protein . Cancer Res. , 57 , 3562 \u2013 3568 ( 1997 ). 9270029 43 ) Landers , J. E. , Haines , D. S. , Strauss , J. F. , 3rd and George , D. L. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells . Oncogene , 9 , 2745 \u2013 2750 ( 1994 ). 8058341 44 ) Keleti , J. , Quezado , M. M. , Abaza , M. M. , Raffeld , M. and Tsokos , M. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild\u2010type p53 protein . Am. J. Pathol. , 49 , 143 \u2013 151 ( 1996 ). 45 ) Zou , M. , Shi , Y. , Al\u2010Sedairy , S. , Hussain , S. S. and Farid , N. R. The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis . Cancer , 76 , 314 \u2013 318 ( 1995 ). 8625108 46 ) Gunther , T. , Schneider\u2010Stock , R. , Rys , J. , Niezabitowski , A. and Roessner , A. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico\u2010pathological factors . J. Cancer Res. Clin. Oncol. , 123 , 388 \u2013 394 ( 1997 ). 9260591 47 ) Bull , E. K. , Chakrabarty , S. , Brodsky , I. and Haines , D. S. mdm2\u2013P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells . Oncogene , 16 , 2249 \u2013 2257 ( 1998 ). 9619834 48 ) Borden , K. L. and Freemont , P. S. The RING finger domain: a recent example of a sequence\u2010structure family . Curr. Opin. Struct. Biol. , 6 , 395 \u2013 401 ( 1996 ). 8804826 49 ) Saurin , A. J. , Hamlett , J. , Clague , M. J. and Pennington , S. R. Inhibition of mitogen\u2010induced DNA synthesis by bafilomycin A1 in Swiss 3T3 fibroblasts . Biochem. J. , 313 , 65 \u2013 70 ( 1996 ). 8546711",
    "full_text_abstract": "The overexpression of the oncogene product MDM2 is often observed in human breast cancer cells, especially in estrogen receptor (ER)\u2010positive ones. To study the role of MDM2 protein in ER\u2010positive breast cancer, we have established cell lines derived from MCF\u20107 which stably express increased and decreased levels of MDM2 by transfection of a mammalian expression vector containing human mdm2 cDNA in sense and antisense orientations, respectively. Interestingly, MDM2 overexpression in MCF\u20107 cells afforded a remarkable growth advantage under estradiol (E2)\u2010sup\u2010plemented condition. Then, we analyzed the expression of p53, which is an important regulator of growth and the cell cycle. Unexpectedly, the p53 accumulation induced by E2 was remarkably higher in MCF\u20107 cells stably overexpressing MDM2 than in the parent MCF\u20107 cells. On the other hand, reduction of MDM2 suppressed the E2\u2010induced increase in p53 protein. Moreover, mdm2 antisense oligonucleotides prevented E 2 \u2010induced accumulation of p53. In the steady state, the cellular levels of p53 were also correlated with those of MDM2. These interactions are not consistent with the well\u2010known role of MDM2, which acts as a negative regulator for p53 by inhibiting its function and promoting its rapid degradation. These results suggest that MDM2 may regulate the expression of p53 in the steady state and in response to E2 in breast cancer cells, and imply a novel and important role of MDM2 during breast carcinogenesis."
}